Device Therapies in the Post-Myocardial Infarction Patient with Left Ventricular Dysfunction

American Journal of Cardiology

Volumn 102, Issue 5 SUPPL., 2008, Pages 29G-37G

  Kadish, Alan H ^a   Reiffel, James A ^b   Naccarelli, Gerald V ^c   DiMarco, John P ^d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; SOTALOL;

ACUTE HEART INFARCTION; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; DEVICE THERAPY; ECHOCARDIOGRAPHY; FOLLOW UP; HEALTH CARE ORGANIZATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART RATE VARIABILITY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIA; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; SUDDEN DEATH; SYSTOLIC DYSFUNCTION; TACHYCARDIA; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TREATMENT PLANNING;

EID: 50949114240     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.06.008     Document Type: Article

References (65)

1. Thom T., Haase N., Rosamond W., Howard V.J., Rumsfeld J., Manolio T., Zheng Z.J., Flegal K., O'Donnell C., Kittner S., et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113 (2006) e85-e151
2. Narang R., Cleland J.G., Erhardt L., Ball S.G., Coats A.J.S., Cowley A.J., Dargief H.J., Hall A.S., Hampton J.R., and Poole-Wilson P.A. Mode of death in chronic heart failure: a request and proposition for more accurate classification. Eur Heart J 17 (1996) 1390-1403
3. Lanza G.A., Guido V., Galeazzi M.M., Mustilli M., Natali R., Ierardi C., Milici C., Burzotta F., Pasceri V., Tomassini F., Lupi A., and Maseri A. Prognostic role of heart rate variability in patients with a recent acute myocardial infarction. Am J Cardiol 82 (1998) 1323-1328
4. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 350 (1997) 1417-1424
5. Centers for Medicare & Medicaid Services. Decision memo for implantable defibrillators. Available at: http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?from2=viewdecisionmemo.a sp&id=148&.
6. Bristow M.R., Saxon L.A., Boehmer J., Krueger S., Kass D.A., De Marco T., Carson P., DiCarlo L., DeMets D., White B.G., DeVries D.W., Feldman A.M., Comparison of Medical Therapy, Pacing, and and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
7. Carson P., Anand I., O'Connor C., Jaski B., Steinberg J., Lwin A., Lindenfeld J., Ghali J., Barnet J.H., Feldman A.M., and Bristow M.R. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. J Am Coll Cardiol 46 (2005) 2329-2334
8. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S., Daubert J.P., Higgins S.L., Brown M.W., Andrews M.L., and Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
9. Greenberg H., Case R.B., Moss A.J., Brown M.W., Carroll E.R., and Andrews M.L. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 43 (2004) 1459-1465
10. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., Domanski M., Troutman C., Anderson J., Johnson G., et al., Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
11. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., Brown M.W., Heo M., and Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335 (1996) 1933-1940
12. Naccarelli G.V. Post myocardial infarction, left ventricular dysfunction, and the expanding role of cardiac implantable electrical devices. Clin Cardiol 28 suppl 1 (2005) I-51-I-57
13. Myerburg R.J., Kessler K.M., and Castellanos A. Sudden cardiac death: structure, function, and time-dependence of risk. Circulation 85 suppl (1992) I2-I10
14. Podrid P.J., and Myerburg R.J. Epidemiology and stratification of risk for sudden cardiac death. Clin Cardiol 28 suppl 1 (2005) I3-I11
15. Josephson M., and Wellens H.J. Implantable defibrillators and sudden cardiac death. Circulation 109 (2004) 2685-2691
16. Bailey J.J., Berson A.S., Handelsman H., and Hodges M. Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. J Am Coll Cardiol 38 (2001) 1902-1911
17. Gold M.R., and Spencer W. T wave alternans for ventricular arrhythmia risk stratification. Curr Opin Cardiol 18 (2003) 1-5
18. Hohnloser S.H., Ikeda T., Bloomfield D.M., Dabbous O.H., and Cohen R.J. T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet 362 (2003) 125-126
19. Bloomfield D.M., Steinman R.C., Namerow P.B., Parides M., Davidenko J., Kaufman E.S., Shinn T., Curtis A., Fontaine J., Holmes D., et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 110 (2004) 1885-1889
20. Hohnloser S.H., Klingenheben T., Bloomfield D., Dabbous O., and Cohen R.J. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. J Am Coll Cardiol 41 (2003) 2220-2224
21. Rashba E.J., Osman A.F., MacMurdy K., Kirk M.M., Sarang S., Peters R.W., Shorofsky S.R., and Gold M.R. Influence of QRS duration on the prognostic value of T wave alternans. J Cardiovasc Electrophysiol 13 (2002) 770-775
22. Bloomfield D.M., Bigger J.T., Steinman R.C., Namerow P.B., Parides M.K., Curtis A.B., Kaufman E.S., Davidenko J.M., Shinn T.S., and Fontaine J.M. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 456-463
23. Costantini O., Rosenbaum D.S., Hohnloser S.H., Kirk M., Lerman B., Baker J.I.I., Sethuraman B., Dettmer M., and ABCD Investigators. The Alternans Before Cardioverter Defibrillator trial: a noninvasive strategy for primary prevention of sudden cardiac death using MTWA [abstract]. Circulation 114 (2006) 2426
24. Kusmirek S.L., and Gold M.R. Dynamic changes of T-wave alternans: does it predict short-term arrhythmia vulnerability [abstract]?. J Cardiovasc Electrophysiol 18 (2007) 518-519
25. Stecker E.C., Zargarian M., Dogra V., John B.T., Kron J., McAnulty J.H., and Chugh S.S. Native QRS duration predicts the occurrence of arrhythmic events in ICD recipients. Europace 8 (2006) 859-862
26. Kashani A., and Barold S.S. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 46 (2005) 2183-2192
27. La Rovere M.T., Bigger Jr. J.T., Marcus F.I., Mortara A., Schwartz P.J., and ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 351 (1998) 478-484
28. Rashba E.J., Estes N.A., Wang P., Schaechter A., Howard A., Zareba W., Couderc J., Perkiomaki J., Levine J., and Kadish A. Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: results from the DEFINITE trial. Heart Rhythm 3 (2006) 281-286
29. Curtis A.B., Bigger J.T., DiMarco J.P., Anderson J.L., and The CABG Patch Trial Investigators. Epicardial cardioverter-defibrillators do not cause postoperative arrhythmias. Am J Cardiol 82 (1998) 1114-1117 A9
30. Hohnloser S.H., Kuck K.H., Dorian P., Roberts R.S., Hampton J.R., Hatala R., Fain E., Gent M., Connolly S.J., and DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351 (2004) 2481-2488
31. Zipes D.P., Camm A.J., Borggrefe M., Buxton A.E., Chaitman B., Fromer M., Gregoratos G., Klein G., Moss A.J., Myerburg R.J., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. J Am Coll Cardiol 48 (2006) e247-e346
32. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., Jessup M., Konstam M.A., Mancini D.M., Michl K., et al., ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (2005) e154-e235
33. Antman E.M., Anbe D.T., Armstrong P.W., Bates E.R., Green L.A., Hand M., Hochman J.S., Krumholz H.M., Kushner F.G., Lamas G.A., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 110 (2004) e82-e292
34. Voigt A., Ezzeddine R., Barrington W., Obiaha-Ngwu O., Ganz L.I., London B., and Saba S. Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001. J Am Coll Cardiol 44 (2004) 855-858
35. Kadish A., Dyer A., Daubert J.P., Quigg R., Estes M., Anderson K.P., Calkins H., Hoch D., Goldberger J., Shalaby A., et al., Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
36. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., Hafley G., and Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341 (1999) 1882-1890
37. Zareba W., and Moss A.J. Noninvasive risk stratification in postinfarction patients with severe left ventricular dysfunction and methodology of the MADIT II noninvasive electrocardiology substudy. J Electrocardiol 36 Suppl (2003) 101-108
38. Wilkoff B.L., Cook J.R., Epstein A.E., Greene H.L., Hallstrom A.P., Hsia H., Kutalek S.P., Sharma A., and Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 288 (2002) 3115-3123
39. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
40. Julian D.G., Camm A.J., Frangin G., Janse M.J., Munoz A., Schwartz P.J., Simon P., and European Myocardial Infarct Amiodarone Trial Investigators. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 349 (1997) 667-674
41. Waldo A.L., Camm A.J., deRuyter H., Friedman P.L., MacNeil D.J., Pauls J.F., Pitt B., Pratt C.M., Schwartz P.J., Veltri E.P., and Survival With Oral D-Sotalol (SWORD) Investigators. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 348 (1996) 7-12
42. Yap Y.G., Duong T., Bland M., Malik M., Torp-Pedersen C., Køber L., Connolly S.J., Marchant B., and Camm J. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials. Eur Heart J 26 (2005) 1385-1393
43. Solomon S.D., Zelenkofske S., McMurray J.J., Finn P.V., Velazquez E., Ertl G., Harsanyi A., Rouleau J.L., Maggioni A., Kober L., et al., Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352 (2005) 2581-2588
44. Gehi A., Haas D., and Fuster V. Primary prophylaxis with the implantable cardioverter-defibrillator: the need for improved risk stratification. JAMA 294 (2005) 958-960
45. Sweeney M.O., Hellkamp A.S., Ellenbogen K.A., Greenspon A.J., Freedman R.A., Lee K.L., Lamas G.A., and Mode Selection Trial (MOST) Investigators. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107 (2003) 2932-2937
46. Best P.J., Hayes D.L., and Stanton M.S. The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 22 (1999) 79-85
47. Stambler B.S., Ellenbogen K.A., Orav E.J., Sgarbossa E.B., Estes III N.A.M., Rizo-Patron C., Kirchhoffer J.B., Hadjis T.A., Goldman L., Lamas G.A., and Pacemaker Selection in the Elderly (PASE) Trial Investigators. Predictors and clinical impact of atrial fibrillation after pacemaker implantation in elderly patients treated with dual chamber versus ventricular pacing. Pacing Clin Electrophysiol 26 (2003) 2000-2007
48. Goldberger Z., and Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA 295 (2006) 809-818
49. Wilkoff B.L., Ousdigian K.T., Sterns L.D., Wang Z.J., Wilson R.D., Morgan J.M., and EMPIRIC Trial Investigators. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol 48 (2006) 330-339
50. Swerdlow C.D., and Friedman P.A. Advanced ICD troubleshooting: Part II. Pacing Clin Electrophysiol 29 (2006) 70-79
51. Goldberger J.J., Horvath G., Inbar S., and Kadish A.H. Utility of predischarge and one-month transvenous implantable defibrillator tests. Am J Cardiol 79 (1997) 822-826
52. Louis A.A., Turner T., Gretton M., Baksh A., and Cleland J.G. A systematic review of telemonitoring for the management of heart failure. Eur J Heart Fail 5 (2003) 583-590
53. Wang T.J., Evans J.C., Benjamin E.J., Levy D., LeRoy E.C., and Vasan R.S. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 108 (2003) 977-982
54. Pfeffer M.A., Braunwald E., Moyé L.A., Basta L., Brown Jr. E.J., Cuddy T.E., Davis B.R., Geltman E.M., Goldman S., Flaker G.C., et al., SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med 327 (1992) 669-677
55. Abraham W.T., and Hayes D.L. Cardiac resynchronization therapy for heart failure. Circulation 108 (2003) 2596-2603
56. Abraham W.T., Young J.B., Leon A.R., Adler S., Bank A.J., Hall S.A., Lieberman R., Liem B., O'Connell J.B., Schroeder J.S., Wheelan K.R., and Multicenter InSync ICD II Study Group. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 110 (2004) 2864-2868
57. Bax J.J., Ansalone G., Breithardt O.A., Derumeaux G., Leclercq C., Schalij M., Sogaard P., St. John Sutton M., and Nihoyannopoulos P. Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use?. A critical appraisal. J Am Coll Cardiol 44 (2004) 1-9
58. Pitzalis M.V., Iacoviello M., Romito R., Massari F., Rizzon B., Luzzi G., Guida P., Andriani A., Mastropasqua F., and Rizzon P. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 40 (2002) 1615-1622
59. Ansalone G., Giannantoni P., Ricci R., Trambaiolo P., Fedele F., and Santini M. Doppler myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving biventricular pacing. J Am Coll Cardiol 39 (2002) 489-499
60. Yu C.M., Bax J.J., Monaghan M., and Nihoyannopoulos P. Echocardiographic evaluation of cardiac dyssynchrony for predicting a favourable response to cardiac resynchronisation therapy. Heart 90 (2004) vi17-vi22
61. Worley S.J., Gohn D.C., and Smith T.M. Optimization of cardiac resynchronization: left atrial electrograms measured at implant eliminates the need for echo and identifies patients where AV optimization is not possible [abstract]. J Card Fail 10 (2004) S62
62. Koglek W., Kranig W., Kowalski M., Kronski D., Brandl J., Oberbichler A., Suntinger A., Wutte M., Grimm G., Grove R., and Lüdorff G. Eine einfache Methode zur Bestimmung des AV-Intervalls bei Zweikammerschrittmachern. Herzschrittmacherther Elektrophysiol 11 (2000) 244-253
63. Trupp R.J. Cardiac resynchronization therapy: a practical guide for device optimization, part I. Congest Heart Fail 12 (2006) 169-173
64. Donal E., Leclercq C., Linde C., and Daubert J.C. Effects of cardiac resynchronization therapy on disease progression in chronic heart failure. Eur Heart J 27 (2006) 1018-1025
65. Trupp R.J. Cardiac resynchronization therapy: a practical guide for patient management after device implantation, part II. Congest Heart Fail 12 (2006) 219-222